Memorial Sloan Kettering hematologic oncologist Aaron Goldberg

Aaron D. Goldberg, MD, PhD

Hematologic Oncologist

Clinical Expertise

Adult Acute and Chronic Leukemias; Acute Myeloid Leukemia (AML); Myelodysplastic Syndrome (MDS); Myeloproliferative Neoplasms (MPNs); Immunotherapy

New Patient Appointments

Scheduling a visit is easy. Click below or call us to get started.

Accepted Insurance Providers

Dr. Goldberg accepts the following list of insurance providers. Select your insurance provider to see more details.

Contact and Location

Locations map

Find a Convenient Location

Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offers many services, including screening, chemotherapy, and medical testing.

About Me


MD, Weill Cornell Medical College; PhD, Rockefeller University


Internal Medicine - Brigham and Women’s Hospital


Hematology/Medical Oncology - Memorial Sloan Kettering Cancer Center

Board Certifications

Internal Medicine; Hematology; Medical Oncology

I am a hematologist and medical oncologist who specializes in caring for people with leukemia and myelodysplastic syndrome. I am board-certified in hematology, medical oncology, and internal medicine. I work as part of a team of doctors and nurses with wide-ranging expertise to bring the most-advanced, comprehensive care in the world to our patients and their families.

Patients often come to me with deep concerns about how their disease will affect their lives. I treat every patient as if they are a member of my family. As a physician, I take time to listen to their concerns and provide thorough answers. As a scientist, I study the molecular features of each patient’s disease to determine which specific therapy will work best to treat them.

At MSK, we have many clinical trials that give our patients access to groundbreaking therapies. These include immunotherapy, epigenetic therapy, and other small-molecule targeted approaches. I lead multiple clinical trials evaluating new treatments designed to specifically target leukemia.

Working with scientific collaborators, I also study leukemia in the laboratory. Our long-term goal is to provide more effective and less toxic therapies for people with acute myeloid leukemia. My colleagues and I are working to advance our field so that we can continue to offer our patients options beyond traditional treatments, such as chemotherapy.

Every day I reflect on what an extraordinary privilege it is to care for people with leukemia and other blood disorders. I hope that all of my patients leave a visit with me knowing that I will work tirelessly to provide them with the best possible care.

Awards and Honors

  • American Society of Hematology Fellow Scholar Award in Clinical Research (2018)
  • Advancing Science through Pfizer Investigator Research Exchange (ASPIRE) Oncology/Hematology Clinical Research Award (2017)
  • American Society of Clinical Oncology Young Investigator Award (2017)
  • Memorial Sloan Kettering Cancer Center Chief Hematology Fellow (2016)
  • Resident Mentor Award, Brigham and Women’s Hospital (2014)
  • Franklyn Ellenbogen Prize in Hematology-Oncology, Weill Cornell Medical College (2011)


Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.

Clinical Trials

Smiling doctors in the lab

Find a Clinical Trial for You

Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.

You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.

Research and Publications

Publications on PubMed

Visit PubMed for a full listing of Dr. Goldberg’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.